UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000021267
Receipt number R000024513
Scientific Title Longitudinal Efficacy and Safety Study of Tolvaptan on Autosomal Dominant Polycystic Kidney Disease Patients
Date of disclosure of the study information 2016/03/12
Last modified on 2021/03/09 10:50:59

No. Disposal Last modified on Item of update
1 Insert 2016/03/01 17:51:22
2 Update 2016/03/12 10:37:27 Date of disclosure of the study information
3 Update 2016/03/23 19:16:06 Acronym
Acronym
4 Update 2016/03/23 20:34:02 Acronym
5 Update 2016/08/12 10:40:23 Name of primary person or sponsor
Organization
Research ethics review
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
6 Update 2016/08/12 11:09:40 Key inclusion criteria
Key inclusion criteria
7 Update 2016/08/12 11:11:57 Date of protocol fixation
Anticipated trial start date
8 Update 2016/08/12 11:40:09 Anticipated trial start date
9 Update 2016/11/01 15:20:10 Recruitment status
Last follow-up date
Date of closure to data entry
Date analysis concluded
10 Update 2017/03/08 13:17:52 Date of protocol fixation
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
11 Update 2018/02/20 17:58:00 Genomic information
Narrative objectives1
Narrative objectives1
Trial characteristics_1
Trial characteristics_2
Developmental phase
Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
12 Update 2018/02/20 19:04:14 Stratification
Interventions/Control_1
Interventions/Control_1


Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
Target sample size
13 Update 2018/02/20 19:12:06 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
14 Update 2018/02/20 19:14:32 Primary outcomes
15 Update 2018/06/13 12:58:02 Study type
Basic design
Randomization
Blinding
Control
Stratification
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_1
16 Update 2018/06/13 13:34:30 Other related information
Other related information
17 Update 2018/08/17 11:31:44 Narrative objectives1
Narrative objectives1
Primary outcomes
Primary outcomes
18 Update 2018/08/17 11:46:28 Organization
Organization
Organization
Organization
Organization
Organization
Institute
Institute
19 Update 2018/08/17 12:20:06 Last follow-up date
Date trial data considered complete
Date analysis concluded
20 Update 2020/03/10 15:43:14 Narrative objectives1
Narrative objectives1
Primary outcomes
Primary outcomes
21 Update 2020/03/10 15:51:53 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Organization1
Organization2
Address2
Tel2
Email2
Organization
Organization
Address
Address
Tel
Email
Institutions
22 Update 2020/03/10 15:54:20 Number of participants that the trial has enrolled
23 Update 2020/03/10 15:58:26 Date of IRB
24 Update 2020/06/04 12:17:28 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
25 Update 2021/03/09 10:50:59 Recruitment status
Date of closure to data entry
Date trial data considered complete
Date analysis concluded